MenaQ7 K2 given millions in research grants. Why?
01-May-2017 | PDF fileDownload PDF Now!
The sole sponsor of the groundbreaking research that has driven our understanding of Vitamin K2, NattoPharma’s MenaQ7® has been the source material for studies that have identified the bone and cardiovascular benefits of K2 as MK-7. This research not only spawned the K2 category, but earned the attention of European research groups eager to see the company continue its important work, awarding NattoPharma millions of Euro in grants.
Now NattoPharma is eager to share the MenaQ7® Advance Delivery Platform™, innovative technologies required to deliver this clinically proven ingredient in any product application.
Learn more about what NattoPharma will be showcasing at Vitafoods 2017 Stand A32!